Lymphoma of the Ocular Adnexa and Skin of Eyelid

Primary Site Histology Staging Type
C441, C690, C695-C696 9590-9699, 9702-9738, 9811-9818, 9820-9837 TNM 7 and Summary Stage

If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual

Notes

M-9590-9699,9702-9738, 9811-9818,9820-9837 C441 Skin of Eyelid C690 Conjunctiva C695 Lacrimal Gland C696 Orbit **Note 1:** This schema is based on the UICC chapters *Hodgkin & Non-Hodgkin Lymphomas,* pages 304-310. * UICC does not define Lymphoma Ocular Adnexa. A list of all possible values are provided for T, N and M (no definitions are available) * Assign Clinical and Pathologic Stage Group using the Lymphoma chapter **Note 2:** Laterality must be coded for this site. **Note 3:** In addition to directly assigning Clinical and Pathologic Stage Group, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Hodgkin & Non-Hodgkin Lymphoma of All Sites* chapter on page 284 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=284).

Main Data Items

Name Default Value Used in Derivation NAACCR Item Required By Metadata
Clinical T No NAACCR #940 None
Clinical N No NAACCR #950 None
Clinical M No NAACCR #960 None
TNM Clin Stage Group 99 Yes NAACCR #970 None
Pathologic T No NAACCR #880 None
Pathologic N No NAACCR #890 None
Pathologic M No NAACCR #900 None
TNM Path Stage Group 99 Yes NAACCR #910 None
SSF1: Associated with HIV/AIDS 999 No NAACCR #2880 CCCR/Canada
COC
SEER		 None
SSF2: Systemic Symptoms at Diagnosis 999 Yes NAACCR #2890 All None
SSF3: International Prognostic Index (IPI) 988 No NAACCR #2900 CCCR/Canada
COC		 None
SSF4: Follicular Lymphoma Prognostic Index (FLIPI) 988 No NAACCR #2910 None None
SSF5: Ki-67/MIB-1 Labeling Index (LI): Ophthalmic 988 No NAACCR #2920 None None
SSF6: Lactate Dehydrogenase (LDH) 988 No NAACCR #2930 CCCR/Canada
COC		 None
SSF7: Rheumatoid Arthritis 988 No NAACCR #2861 None None
SSF8: Sjogren Syndrome 988 No NAACCR #2862 None None
SSF9: Other Connective Tissue Disease 988 No NAACCR #2863 None None
SSF10: Sicca Syndrome 988 No NAACCR #2864 None None

Additional Data Items

Name Default Value Used in Derivation NAACCR Item Required By Metadata
Year of Diagnosis No NAACCR #390 None
Primary Site Yes NAACCR #400 None
Histology Yes NAACCR #522 None

Initial Context

Staging Methods

Expand All | Collapse All

TNM 7 Stage

Inclusion Table

Histology
9590-9699
9702-9738
9811-9818
9820-9837

Start

Additional Context
Pathologic Stage Group = 90
Clinical Stage Group = 90

Next Step

  2. Lymphoma Stage Group Detailed
  3. Clinical Stage Group

Next Step

  2. Lymphoma Path Stage Group Detailed
  3. Pathologic Stage Group

End

Combined Stage

Inclusion Table

Histology
9590-9699
9702-9738
9811-9818
9820-9837

Start

Additional Context
Combined Stage Group = 90

Next Step

  2. Combined Stage Group for Lymphoma
  3. Combined Stage Group

End

Outputs

Name Default Value Description NAACCR Item Metadata
Derived Version {{ctx_alg_version}} None None
Derived SEER Clin Stage Group 88 NAACCR #3610
None 		None
Derived SEER Path Stage Group 88 NAACCR #3605
None 		None
Derived SEER Combined Stage Group 88 NAACCR #3614
None 		None
Derived SEER Combined T 88 NAACCR #3616
None 		None
Derived SEER Combined N 88 NAACCR #3618
None 		None
Derived SEER Combined M 88 NAACCR #3620
None 		None
Derived SEER Combined T Source <BLANK> NAACCR #3622
None 		None
Derived SEER Combined N Source <BLANK> NAACCR #3624
None 		None
Derived SEER Combined M Source <BLANK> NAACCR #3626
None 		None